Year: 2025

Zhimeng Biopharma’s Next-Generation KCNQ2/3 Potassium Channel Opener Receives Clinical Trial Approval for ALS Phase 2/3 Study

SHANGHAI, July 9, 2025 /PRNewswire/ -- Shanghai Zhimeng Biopharma, Inc. ("Zhimeng Biopharma"), a clinical-stage biopharmaceutical company dedicated to innovative drug...

Careington Launches Strategic Relationship With e123 to Expand Noninsurance Benefits Offerings Available Through Streamlined Enrollment Portal

Three Careington savings plans have been added to the expansive suite of products supported by e123's platform. FRISCO, Texas, July...

Landmark Study Shows Ultromics’ EchoGo® Amyloidosis Significantly Improves Detection of Cardiac Amyloidosis with Echocardiography

Cardiac amyloidosis is an often-missed, life-threatening cause of heart failure. As new disease-modifying therapies emerge, timely and earlier diagnosis is critical.EchoGo®...

Connect Biopharma’s Exclusive Licensee in China, Simcere Pharmaceutical, Announced Submission of its New Drug Application for Rademikibart for the Treatment of Atopic Dermatitis in China

SAN DIEGO, July 09, 2025 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (“Connect Biopharma”, “Connect”, or the “Company”),...

error: Content is protected !!